Facebook
Twitter
LinkedIn
ForwardRecognizing Early Signs and Symptoms of Progressive Multifocal Leukoencephalopathy
| Registration |
|---|
Before enrolling in this educational activity, you must log in or create an account. Once you register for the course, you will have 30 days from the date of enrollment to complete the course. The date your access expires will be indicated in the Course Summary box on this webpage. |
Target Audience
Healthcare professionals.
Educational Need
Progressive multifocal leukoencephalopathy is rare and is often underdiagnosed or even missed altogether. Patients who go through this diagnosis are scared and often not educated as to the progression of said disease. If patients were more educated, they could fulfill the last months and days of their lives how they wish. It would bring them dignity and peace while dying along with their family. Primary care providers often overlook these signs or dismiss them as old age and do not work up for it.
Learning Objectives
- Recognize early signs of progressive multifocal leukoencephalopathy (PML)
- Define PML.
- Review the current management of PML.
- Review the current need for research related to PML.
Speaker
Ashley Stang
Physician Assistant Student, Des Moines University Medicine and Health Sciences
Faculty Advisor
Kenna Willey, PA-C
Assistant Professor, Master of Science in Physician Assistant Studies Program, Des Moines University Medicine and Health Sciences
Ms. Willey has reviewed the slides for completeness, clinical accuracy, and recommended action.
Terms of Use and Privacy Policy
Recording date: April 15, 2024
Date of original release: April 15, 2024
Most recent review/update: April 15, 2024
Termination date: April 14, 2027
Accreditation Statements
MD: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Iowa Medical Society (IMS). Des Moines University Medicine and Health Sciences (DMU) is accredited by the IMS to provide continuing medical education for physicians. DMU designates this enduring materials activity for a maximum of 0.25 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.- DO: Des Moines University Medicine and Health Sciences (DMU) is accredited by the American Osteopathic Association (AOA) to provide osteopathic continuing medical education for physicians. DMU designates this activity for a maximum of 0.25 AOA Category 2-B credits and will report CME and specialty credits commensurate with the extent of the physician’s participation in this activity.
- Other Healthcare Professionals: This enduring materials activity is designated for a maximum of 0.25 AMA PRA Category 1 Credit(s)™.
Educational Grants
No ineligible company provided financial support for this continuing education activity.
DISCLOSURE
The planning committee member(s) and speaker(s) will disclose if any pharmaceuticals or medical procedures and devices discussed are investigational or unapproved for use by the U.S. Food and Drug Administration (FDA). The determination of educational content and the selection of speakers is the responsibility of the activity director.
Relevant to the content of this educational activity, the following individual(s) have no conflict(s) with ineligible companies to disclose.
- Ashley Stang - Speaker
- Kenna Willey, PA-C - Faculty Advisor and Content Reviewer
Disclaimer
The information provided in this activity is for continuing education purposes only. It is not a substitute for a healthcare provider's independent medical judgment regarding diagnostic and treatment options for a specific patient's medical condition. The content of this educational offering does not reflect the views of Des Moines University Medicine and Health Sciences.
Available Credit
- 0.25 AMA PRA Category 1 Credits™
- 0.25 AOA Category 2B
- 0.25 CE Contact Hour(s)